Mitsui & Co has taken a 5% stake in Indian active pharmaceutical ingredients manufacturer Arch Pharmalabs in a $13 million …
Jager-van Dijk is new Arletta Pharma Solutions CEOÂ
Tridem begins phase Ib trial of Parkinson’s disease vaccine
Trio become latest Symbiosis commercial additions
UK immunoglobulin supply faces growing pressure, report warns

